Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06672575
What this trial is testing

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center 45
Large-scale testing (Phase 3)Temporarily pausedNCT02546102
What this trial is testing

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Precision Life Sciences Group 234
Very early researchEnded earlyNCT04712721
What this trial is testing

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Who this might be right for
Glioblastoma MultiformeBrain NeoplasmsGastroesophageal Adenocarcinoma+1 more
Novartis Pharmaceuticals 14
Early research (Phase 1)Study completedNCT01172964
What this trial is testing

A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaRecurrent Grade III GliomaRecurrent Grade IV Glioma+9 more
City of Hope Medical Center 15
Not applicableNot Yet RecruitingNCT07492836
What this trial is testing

Hypofractionated Radiotherapy Plus Temozolamide in Patients Younger Than 70 Years With Glioblastoma

Who this might be right for
Glioblastoma (GBM)
Hospital do Coracao 10
Testing effectiveness (Phase 2)Ended earlyNCT01227434
What this trial is testing

PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma
University of California, San Francisco 23
Not applicableUnknownNCT04717999
What this trial is testing

Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
UWELL Biopharma 20
Not applicableNot Yet RecruitingNCT07274787
What this trial is testing

Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma

Who this might be right for
GBM
University of Cincinnati 10
Not applicableStudy completedNCT04734444
What this trial is testing

SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue

Who this might be right for
Brain TumourHigh Grade GliomaLow-grade Glioma+1 more
SonoClear AS 45
Large-scale testing (Phase 3)Study completedNCT00820963
What this trial is testing

Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Centre Leon Berard 70
Testing effectiveness (Phase 2)UnknownNCT01181193
What this trial is testing

Vitamin D for Treatment of Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Soroka University Medical Center 20
Very early researchActive Not RecruitingNCT07585851
What this trial is testing

Administration of Repurposed Ketoconazole in Glioma Patients

Who this might be right for
Diffuse GliomaDiffuse Glioma, Grade IDiffuse Glioma, Grade II+2 more
Universitas Padjadjaran 80
Early research (Phase 1)Study completedNCT04019002
What this trial is testing

Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma

Who this might be right for
Glioblastoma Multiforme (GBM)
Susan Chang 17
Early research (Phase 1)Looking for participantsNCT06815029
What this trial is testing

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 3Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma
City of Hope Medical Center 27
Early research (Phase 1)Study completedNCT02122822
What this trial is testing

Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96

Who this might be right for
Glioma
Cure&Sure Biotech Co., LTD 20
Testing effectiveness (Phase 2)Looking for participantsNCT06327451
What this trial is testing

Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtype
Tianjin Medical University General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01067469
What this trial is testing

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma
M.D. Anderson Cancer Center 83
Not applicableLooking for participantsNCT03526822
What this trial is testing

Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.

Who this might be right for
Brain Tumor
Assistance Publique Hopitaux De Marseille 100
Testing effectiveness (Phase 2)Looking for participantsNCT07416188
What this trial is testing

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeRelapsed Cancer+12 more
National Institute of Neurological Disorders and Stroke (NINDS) 40
Testing effectiveness (Phase 2)Study completedNCT00782756
What this trial is testing

Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Brain CancerMalignant Glioma
Memorial Sloan Kettering Cancer Center 40
Next Page